Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prachi Mishra

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
The Journal of Clinical Investigation|December 5, 2017
ADHFE1 is a breast cancer oncogene and induces metabolic reprogrammingPrachi Mishra, Wei Tang, Vasanta Putluri, et al.
Journal of Translational Medicine|January 9, 2020
Multi-omic serum biomarkers for prognosis of disease progression in prostate cancerMichael A Kiebish, Jennifer Cullen, Prachi Mishra, et al.
The Journal of Clinical Investigation|December 10, 2013
MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosisAtsushi Terunuma, Nagireddy Putluri, Prachi Mishra, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
The Journal of Clinical Investigation|December 5, 2017
ADHFE1 is a breast cancer oncogene and induces metabolic reprogrammingPrachi Mishra, Wei Tang, Vasanta Putluri, et al.
Journal of Translational Medicine|January 9, 2020
Multi-omic serum biomarkers for prognosis of disease progression in prostate cancerMichael A Kiebish, Jennifer Cullen, Prachi Mishra, et al.
The Journal of Clinical Investigation|December 10, 2013
MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosisAtsushi Terunuma, Nagireddy Putluri, Prachi Mishra, et al.
Pageof 3